Company intelligence / Profile preview

CryptoLab

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

CryptoLab is a leading cybersecurity company specializing in fully homomorphic encryption (FHE), post-quantum cryptography, and privacy-preserving artificial intelligence; the technology is used to secure sensitive data including in healthcare and finance and has been validated through high-profile partnerships and patent activity, but they do not advance any clinical or therapeutic programs.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

UClone (integration of FHE for privacy-preserving AI agents, including for sensitive data such as healthcare applications)

Beyond the preview

Go deeper on CryptoLab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CryptoLab.

Explore the full profile